Spartannash Co (SPTN) Financials
Newest figures come from the 10-Q for Q3 FY2025, filed Aug 14, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SPTN SEC filings page.
Spartannash Co (SPTN) reported $9.5B in revenue for fiscal year 2024, down 1.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
SpartanNash’s dominant mechanic is thin-margin retail economics: gross profit holds, but overhead, interest, and reinvestment absorb most earnings.
Gross margin expanded to15.8% while revenue contracted1.8% ; that combination points to pressure below gross profit, where costs did not flex with sales. Net income of$299K contrasted with operating cash flow of$205.9M , indicating accounting earnings were depressed by non-cash charges or timing rather than weak cash collection.
Capital intensity is becoming more consequential: capital expenditures rose from
The balance sheet became more liability-funded: total liabilities rose
Financial Health Signals
Scored against operating companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Spartannash Co's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Spartannash Co has an operating margin of 0.6%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 45/100, indicating healthy but not exceptional operating efficiency. This is down from 1.1% the prior year.
Spartannash Co's revenue declined 1.8% year-over-year, from $9.7B to $9.5B. This contraction results in a growth score of 29/100.
Spartannash Co has elevated debt relative to equity (D/E of 2.50), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 26/100, reflecting increased financial risk.
Spartannash Co's current ratio of 1.57 indicates adequate short-term liquidity, earning a score of 44/100. The company can meet its near-term obligations, though with limited headroom.
Spartannash Co's free cash flow margin of 0.8% results in a low score of 26/100. Capital expenditures of $132.4M absorb a large share of operating cash flow.
Spartannash Co's ROE of 0.0% shows moderate profitability relative to equity, earning a score of 53/100. This is down from 6.7% the prior year.
Spartannash Co scores 4.37, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Spartannash Co passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Spartannash Co reported $299K of net income while generating $205.9M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.
Spartannash Co earns $1.20 in operating income for every $1 of interest expense ($54.0M vs $44.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Spartannash Co generated $2.3B in revenue in Q3 2025. This represents an increase of 1.8% from the same quarter a year earlier. Against the prior quarter it is down 21.9%.
Spartannash Co's EBITDA was $46.0M in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.0% from the same quarter a year earlier. Against the prior quarter it is down 17.6%.
Spartannash Co reported $6.2M in net income in Q3 2025. This represents a decrease of 46.1% from the same quarter a year earlier. Against the prior quarter it is up 197.6%.
Spartannash Co earned $0.18 per diluted share (EPS) in Q3 2025. This represents a decrease of 47.1% from the same quarter a year earlier. Against the prior quarter it is up 200.0%.
Cash & Balance Sheet
Spartannash Co generated $67.1M in free cash flow in Q3 2025, representing cash available after capex. This represents a decrease of 2.3% from the same quarter a year earlier. Against the prior quarter it is up 1264.8%.
Spartannash Co held $25.5M in cash as of Q3 2025; long-term debt is not reported for that period.
Spartannash Co paid $0.22 per share in dividends in Q3 2025. This represents an increase of 1.1% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Spartannash Co's gross margin was 16.9% in Q3 2025, indicating the percentage of revenue retained after direct costs. This is up 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
Spartannash Co's operating margin was 0.8% in Q3 2025, reflecting core business profitability. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.
Spartannash Co's net profit margin was 0.3% in Q3 2025, showing the share of revenue converted to profit. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.
Spartannash Co's ROE was 0.8% in Q3 2025, measuring profit generated per dollar of shareholder equity. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.
Capital Allocation
Spartannash Co repurchased no shares in Q3 2025. This represents a decrease of 100.0% from the same quarter a year earlier.
Spartannash Co invested $19.6M in capex in Q3 2025, funding long-term assets and infrastructure. This represents a decrease of 27.2% from the same quarter a year earlier. Against the prior quarter it is down 38.0%.
Not reported for Q3 2025.
SPTN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3B+1.8% | $2.9B+3.7% | $2.3B-0.6% | $2.2B-3.5% | $2.8B-3.5% | $2.3B-1.4% | $2.3B+1.7% | $2.9B+5.2% |
| Cost of Revenue | $1.9B+0.6% | $2.4B+2.6% | $1.9B-1.1% | $1.9B-4.2% | $2.4B-3.9% | $1.9B-1.5% | $2.0B+2.1% | $2.5B+6.4% |
| Gross Profit | $382.6M+8.4% | $481.5M+9.3% | $354.6M+2.0% | $353.0M+0.2% | $440.3M-1.4% | $347.5M-1.0% | $352.4M-0.5% | $446.7M-0.9% |
| SG&A Expenses | $355.3M+11.7% | $459.1M+13.7% | $324.1M+0.4% | $318.2M-0.2% | $403.6M-3.5% | $322.8M-3.2% | $318.8M-5.9% | $418.2M-0.9% |
| Operating Income | $18.1M-30.6% | $19.0M-38.1% | $24.9M+8.0% | $26.1M-27.0% | $30.6M+25.9% | $23.1M+19.5% | $35.8M+190.3% | $24.3M-13.6% |
| EBITDA | $46.0M-7.0% | $55.8M-8.9% | $49.1M+6.4% | $49.5M-15.1% | $61.3M+13.3% | $46.1M+12.1% | $58.2M+69.8% | $54.1M-4.5% |
| Interest Expense | $12.3M+16.5% | $15.2M+12.8% | $9.9M+6.8% | $10.5M+12.8% | $13.5M+16.4% | $9.3M+53.4% | $9.3M+106.5% | $11.6M+176.9% |
| Income Tax | -$138K-103.0% | $1.9M-63.1% | $4.3M+24.6% | $4.6M-39.3% | $5.2M+114.6% | $3.5M-24.2% | $7.7M+266.9% | $2.4M-50.4% |
| Net Income | $6.2M-46.1% | $2.1M-84.0% | $10.9M-1.9% | $11.5M-41.0% | $13.0M+14.4% | $11.1M+17.6% | $19.5M+280.6% | $11.3M-41.2% |
| EPS (Basic) | $0.18-47.1% | $0.06-84.2% | $0.330.0% | $0.34-40.4% | $0.38+15.2% | $0.33+22.2% | $0.57+307.1% | $0.33-38.9% |
| EPS (Diluted) | $0.18-47.1% | $0.06-83.8% | $0.320.0% | $0.34-39.3% | $0.37+15.6% | $0.32+23.1% | $0.56+300.0% | $0.32-39.6% |
| Diluted Shares (Avg) | 34M+1.4% | 34M-1.5% | 34M-1.2% | 34M-2.0% | 35M-2.4% | 35M-3.5% | 35M-4.2% | 35M-1.2% |
Not reported in any period shown, so not listed: R&D Expenses.
SPTN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.6B+8.1% | $2.6B+10.2% | $2.5B+5.7% | $2.4B+1.7% | $2.3B+2.0% | $2.3B-0.3% | $2.3B+0.2% | $2.3B+1.4% |
| Current Assets | $1.1B+4.1% | $1.1B+3.0% | $1.1B+4.8% | $1.0B-3.7% | $1.1B-0.3% | $1.1B-5.1% | $1.1B-3.2% | $1.1B+3.6% |
| Cash & Equivalents | $25.5M+1.0% | $20.0M+5.3% | $17.5M-0.3% | $25.2M+49.3% | $19.0M+11.8% | $17.6M-7.4% | $16.9M-20.3% | $17.0M+3.9% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $530.1M+0.5% | $527.4M-5.0% | $558.0M-3.7% | $527.6M-8.5% | $555.4M-1.9% | $579.6M-7.0% | $576.9M-2.5% | $566.3M+1.8% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $181.0M-4.8% | $181.0M-0.6% | $190.0M+4.3% | $190.2M+4.4% | $182.2M0.0% | $182.2M0.0% | $182.2M0.0% | $182.2M+0.6% |
| Total Liabilities | $1.8B+14.2% | $1.8B+18.3% | $1.7B+8.3% | $1.6B+2.0% | $1.6B+1.3% | $1.6B-0.3% | $1.6B+2.0% | $1.5B+4.6% |
| Current Liabilities | $693.5M+7.8% | $662.6M+9.0% | $701.6M+2.8% | $643.3M-4.1% | $608.0M-4.1% | $682.4M-2.9% | $670.5M-4.8% | $634.2M-4.1% |
| Non-Current Liabilities | $1.1B+18.6% | $1.2B+24.2% | $984.5M+12.6% | $946.3M+6.6% | $948.6M+5.1% | $874.1M+1.8% | $888.0M+7.7% | $902.5M+11.8% |
| Total Equity | $741.8M-4.4% | $739.5M-5.8% | $781.3M+0.5% | $776.3M+1.0% | $785.2M+3.4% | $777.3M-0.4% | $768.4M-3.2% | $759.5M-4.5% |
| Retained Earnings | $280.1M-14.1% | $281.6M-12.6% | $329.6M+4.9% | $326.3M+5.0% | $322.4M+7.9% | $314.3M+4.2% | $310.6M+3.6% | $298.7M-1.2% |
Not reported in any period shown, so not listed: Accounts Receivable, Long-Term Debt.
SPTN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $86.7M-9.3% | $25.8M-29.2% | -$8.8M-119.2% | $95.6M+82.6% | $36.5M+1446.5% | $46.0M+318.5% | $52.4M+182.3% | -$2.7M-127.2% |
| Depreciation & Amortization | $27.9M+19.4% | $36.8M+20.2% | $24.2M+4.8% | $23.3M+3.9% | $30.6M+3.0% | $23.0M+5.5% | $22.5M+2.2% | $29.7M+4.5% |
| Stock-Based Compensation | N/A | $5.6M+51.7% | N/A | N/A | $3.7M-27.7% | N/A | N/A | $5.1M+19.8% |
| Capital Expenditures | $19.6M-27.2% | $31.6M-21.3% | $30.8M+21.3% | $26.9M+22.5% | $40.2M+3.3% | $25.4M+27.9% | $22.0M+33.1% | $38.9M+29.8% |
| Free Cash Flow | $67.1M-2.3% | -$5.8M-55.8% | -$39.6M-292.1% | $68.7M+126.0% | -$3.7M+91.1% | $20.6M+150.4% | $30.4M+1378.8% | -$41.6M-108.2% |
| Investing Cash Flow | -$22.5M+45.7% | -$37.0M+3.0% | -$31.2M-24.9% | -$41.4M-132.8% | -$38.1M+3.0% | -$24.9M-625.1% | -$17.8M+25.2% | -$39.3M-45.8% |
| Financing Cash Flow | -$58.7M-22.4% | $9.5M+260.4% | $32.3M+257.9% | -$48.0M-38.5% | $2.6M-91.1% | -$20.4M-245.3% | -$34.6M-443.0% | $29.9M+31.9% |
| Dividends Paid | $7.7M+1.4% | $8.0M-0.6% | $7.6M+1.3% | $7.6M+0.8% | $8.1M+3.4% | $7.5M+0.5% | $7.5M-0.5% | $7.8M+1.4% |
| Share Buybacks | $0-100.0% | $0-100.0% | $0 | $12.4M+63.3% | $2.6M-76.0% | $0-100.0% | $7.6M+15.9% | $10.9M |
SPTN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 16.9%+1.0pp | 16.6%+0.9pp | 15.8%+0.4pp | 15.8%+0.6pp | 15.7%+0.3pp | 15.3%+0.1pp | 15.2%-0.3pp | 15.4%-0.9pp |
| Operating Margin | 0.8%-0.4pp | 0.7%-0.4pp | 1.1%+0.1pp | 1.2%-0.4pp | 1.1%+0.3pp | 1.0%+0.2pp | 1.6%+1.0pp | 0.8%-0.2pp |
| Net Margin | 0.3%-0.2pp | 0.1%-0.4pp | 0.5%0.0pp | 0.5%-0.3pp | 0.5%+0.1pp | 0.5%+0.1pp | 0.8%+0.6pp | 0.4%-0.3pp |
| Return on Equity | 0.8%-0.7pp | 0.3%-1.4pp | 1.4%0.0pp | 1.5%-1.0pp | 1.7%+0.2pp | 1.4%+0.2pp | 2.5%+1.9pp | 1.5%-0.9pp |
| Return on Assets | 0.2%-0.3pp | 0.1%-0.5pp | 0.4%0.0pp | 0.5%-0.3pp | 0.5%+0.1pp | 0.5%+0.1pp | 0.8%+0.6pp | 0.5%-0.4pp |
| Current Ratio | 1.57-0.1x | 1.66-0.1x | 1.620.0x | 1.620.0x | 1.75+0.1x | 1.590.0x | 1.620.0x | 1.69+0.1x |
| Debt-to-Equity | 2.45+0.4x | 2.49+0.5x | 2.16+0.2x | 2.050.0x | 1.980.0x | 2.000.0x | 2.03+0.1x | 2.02+0.2x |
| Asset Turnover | 0.89-0.1x | 1.13-0.1x | 0.91-0.1x | 0.94-0.1x | 1.20-0.1x | 0.970.0x | 0.990.0x | 1.270.0x |
| FCF Margin | 3.0%-0.1pp | -0.2%-0.1pp | -1.8%-2.7pp | 3.1%+1.8pp | -0.1%+1.3pp | 0.9%+2.7pp | 1.3%+1.2pp | -1.4%-0.7pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Spartannash Co SPTN | FY2024 | $9.5B | $299K | 0.0% | $910.9M | 37/100 |
| Mission Produce, Inc. AVO | FY2025 | $1.4B | $37.7M | 2.7% | $1.1B | 56/100 |
| United Natural Foods UNFI | FY2025 | $31.8B | -$118.0M | -0.4% | $2.7B | 30/100 |
| Calavo Growers CVGW | FY2025 | $648.4M | $19.8M | 3.0% | $466.3M | 50/100 |
| Andersons Inc ANDE | FY2025 | $11.0B | $95.7M | 0.9% | $2.4B | 23/100 |
| G Willi Food Intl Ltd WILC | FY2025 | $191.4M | $28.3M | 14.8% | $397.2M | 49/100 |
Where Spartannash Co Ranks
Frequently Asked Questions
What is Spartannash Co's annual revenue?
Spartannash Co (SPTN) reported $9.5B in total revenue for fiscal year 2024. This represents a -1.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Spartannash Co's revenue growing?
Spartannash Co (SPTN) revenue declined by 1.8% year-over-year, from $9.7B to $9.5B in fiscal year 2024.
Is Spartannash Co profitable?
Yes, Spartannash Co (SPTN) reported a net income of $299K in fiscal year 2024, with a net profit margin of 0.0%.
What is Spartannash Co's EBITDA?
Spartannash Co (SPTN) had EBITDA of $157.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Spartannash Co's gross margin?
Spartannash Co (SPTN) had a gross margin of 15.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Spartannash Co's operating margin?
Spartannash Co (SPTN) had an operating margin of 0.6% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Spartannash Co's net profit margin?
Spartannash Co (SPTN) had a net profit margin of 0.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does Spartannash Co pay dividends?
Yes, Spartannash Co (SPTN) paid $0.87 per share in dividends during fiscal year 2024.
What is Spartannash Co's return on equity (ROE)?
Spartannash Co (SPTN) has a return on equity of 0.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Spartannash Co's free cash flow?
Spartannash Co (SPTN) generated $73.5M in free cash flow during fiscal year 2024. This represents a 337.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Spartannash Co's operating cash flow?
Spartannash Co (SPTN) generated $205.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Spartannash Co's total assets?
Spartannash Co (SPTN) had $2.6B in total assets as of fiscal year 2024, including both current and long-term assets.
What are Spartannash Co's capital expenditures?
Spartannash Co (SPTN) invested $132.4M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
What is Spartannash Co's current ratio?
Spartannash Co (SPTN) had a current ratio of 1.57 as of fiscal year 2024, which is generally considered healthy.
What is Spartannash Co's debt-to-equity ratio?
Spartannash Co (SPTN) had a debt-to-equity ratio of 2.50 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Spartannash Co's return on assets (ROA)?
Spartannash Co (SPTN) had a return on assets of 0.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Spartannash Co's Altman Z-Score?
Spartannash Co (SPTN) has an Altman Z-Score of 4.37, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Spartannash Co's Piotroski F-Score?
Spartannash Co (SPTN) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Spartannash Co's earnings high quality?
Spartannash Co (SPTN) reported $299K of net income while generating $205.9M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Spartannash Co cover its interest payments?
Spartannash Co (SPTN) has an interest coverage ratio of 1.20x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Spartannash Co?
Spartannash Co (SPTN) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.